UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

Journal of clinical oncology, 2005-09, Vol.23 (25), p.5983-5992

2005

Volltextzugriff (PDF)

The Use of Alternate, Non–Cross-Resistant Adjuvant Chemotherapy on the Basis of Pathologic Response to a Neoadjuvant Doxorubicin-Based Regimen in Women With Operable Breast Cancer: Long-Term Results From a Prospective Randomized Trial

Journal of clinical oncology, 2004-06, Vol.22 (12), p.2294-2302

2004

Volltextzugriff (PDF)

Advances in breast cancer treatment: the emerging role of ixabepilone

Expert review of anticancer therapy, 2010-01, Vol.10 (1), p.23-32

Frye, Debra K

2010

Volltextzugriff (PDF)

Capecitabine-based combination therapy for breast cancer: implications for nurses

Oncology nursing forum, 2009-01, Vol.36 (1), p.105-113

Frye, Debra K

2009

Volltextzugriff (PDF)

Evaluation of Paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: Preliminary data of a prospective randomized trial

Clinical cancer research, 2002-05, Vol.8 (5), p.1073-1079

2002

Volltextzugriff (PDF)

Long-Term Results of Combined-Modality Therapy for Locally Advanced Breast Cancer With Ipsilateral Supraclavicular Metastases: The University of Texas M.D. Anderson Cancer Center Experience

Journal of clinical oncology, 2001-02, Vol.19 (3), p.628-633

2001

Volltextzugriff (PDF)

Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy

The cancer journal (Sudbury, Mass.), 2008-01, Vol.14 (1), p.62-68

2008

Volltextzugriff (PDF)

Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer

Journal of clinical oncology, 1999-11, Vol.17 (11), p.3412-3417

1999

Volltextzugriff (PDF)

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

JNCI : Journal of the National Cancer Institute, 2000-02, Vol.92 (3), p.225-233

2000

Volltextzugriff (PDF)

Recommendations for Enhancing Clinical Trials Education: a Review of the Literature

Journal of cancer education, 2011-03, Vol.26 (1), p.64-71

2011

Volltextzugriff (PDF)

Phase I Study of Prolonged-Infusion Gemcitabine Combined with Cyclophosphamide in Patients with Metastatic Carcinoma of the Breast: Tolerability of an Optimal Dose Schedule

Oncology, 2009-01, Vol.77 (1), p.63-70

2009

Volltextzugriff (PDF)

New Options for Metastatic Breast Cancer

Clinical journal of oncology nursing, 2009-02, Vol.13, p.11-18

2009

Volltextzugriff (PDF)

Current Clinical Issues in Systemic Therapy for Metastatic Breast Cancer

Clinical journal of oncology nursing, 2009-02, Vol.13, p.4-10

2009

Volltextzugriff (PDF)

A Phase I and Pharmacokinetic Study of TAS-108 in Postmenopausal Female Patients with Locally Advanced, Locally Recurrent Inoperable, or Progressive Metastatic Breast Cancer

Clinical cancer research, 2004-08, Vol.10 (16), p.5425-5431

2004

Volltextzugriff (PDF)

Multicenter Phase II Study of a 28-Day Regimen of Orally Administered Eniluracil and Fluorouracil in the Treatment of Patients With Anthracycline- and Taxane-Resistant Advanced Breast Cancer

Journal of clinical oncology, 2002-02, Vol.20 (4), p.987-993

Rivera, E.

2002

Volltextzugriff (PDF)

Phase I study of eniluracil and oral 5‐fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma

Cancer, 2002-05, Vol.94 (9), p.2321-2326

2002

Volltextzugriff (PDF)

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

JNCI : Journal of the National Cancer Institute, 1991-12, Vol.83 (24), p.1797-1805

1991

Volltextzugriff (PDF)

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

Journal of clinical oncology, 1997-10, Vol.15 (10), p.3171-3177

1997

Volltextzugriff (PDF)

First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

Breast cancer research : BCR, 2003-01, Vol.5 (5), p.R114-R120, Article R114

2003

Volltextzugriff (PDF)

Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy

The cancer journal (Sudbury, Mass.), 2001-09, Vol.7 (5), p.413

2001

Volltextzugriff (PDF)

The prognostic significance of sialyl‐tn Antigen in women treated with breast carcinoma treated with adjuvant chemotherapy

Cancer, 1997-12, Vol.80 (12), p.2240-2249

1997

Volltextzugriff (PDF)

Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy

Cancer, 2000-05, Vol.88 (9), p.2054-2060

2000

Volltextzugriff (PDF)

Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up : the M.D. Anderson experience

Cancer chemotherapy and pharmacology, 1999, Vol.43 (6), p.471-478

1999

Volltextzugriff (PDF)

Herceptin Plus Chemotherapy Combination in Preoperative Regimen May Offer Clinical Benefit in Early Stage Breast Cancer

Cancer biology & therapy, 2005-05, Vol.4 (5), p.500-500

2005

Volltextzugriff (PDF)

1 – 25 von 79

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(79)

Sprache

Englisch
(79)

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(58)
Humans
(51)
Female
(39)
Oncology
(37)
Middle Aged
(34)
Biological And Medical Sciences
(30)
Medical Sciences
(30)
Aged
(28)
Breast Neoplasms - Drug Therapy
(28)
Adult
(27)
Antineoplastic Agents
(20)
Breast Neoplasms - Pathology
(20)
Chemotherapy
(20)
Pharmacology. Drug Treatments
(20)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Male
(14)
Fluorouracil - Administration & Dosage
(13)
Cyclophosphamide - Administration & Dosage
(12)
Doxorubicin - Administration & Dosage
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer

Weekly Paclitaxel Improves Pathologic Complete Remission in Operable Breast Cancer When Compared With Paclitaxel Once Every 3 Weeks

The Use of Alternate, Non–Cross-Resistant Adjuvant Chemotherapy on the Basis of Pathologic Response to a Neoadjuvant Doxorubicin-Based Regimen in Women With Operable Breast Cancer: Long-Term Results From a Prospective Randomized Trial

Advances in breast cancer treatment: the emerging role of ixabepilone

Capecitabine-based combination therapy for breast cancer: implications for nurses

Evaluation of Paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: Preliminary data of a prospective randomized trial

Long-Term Results of Combined-Modality Therapy for Locally Advanced Breast Cancer With Ipsilateral Supraclavicular Metastases: The University of Texas M.D. Anderson Cancer Center Experience

Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy

Prospective Evaluation of Paclitaxel Versus Combination Chemotherapy With Fluorouracil, Doxorubicin, and Cyclophosphamide as Neoadjuvant Therapy in Patients With Operable Breast Cancer

Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma

Recommendations for Enhancing Clinical Trials Education: a Review of the Literature

Phase I Study of Prolonged-Infusion Gemcitabine Combined with Cyclophosphamide in Patients with Metastatic Carcinoma of the Breast: Tolerability of an Optimal Dose Schedule

New Options for Metastatic Breast Cancer

Current Clinical Issues in Systemic Therapy for Metastatic Breast Cancer

A Phase I and Pharmacokinetic Study of TAS-108 in Postmenopausal Female Patients with Locally Advanced, Locally Recurrent Inoperable, or Progressive Metastatic Breast Cancer

Multicenter Phase II Study of a 28-Day Regimen of Orally Administered Eniluracil and Fluorouracil in the Treatment of Patients With Anthracycline- and Taxane-Resistant Advanced Breast Cancer

Phase I study of eniluracil and oral 5‐fluorouracil in combination with docetaxel in the treatment of patients with metastatic breast carcinoma

Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

First-cycle absolute neutrophil count can be used to improve chemotherapy-dose delivery and reduce the risk of febrile neutropenia in patients receiving adjuvant therapy: a validation study

Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy

The prognostic significance of sialyl‐tn Antigen in women treated with breast carcinoma treated with adjuvant chemotherapy

Combined modality treatment of locally advanced breast carcinoma in elderly patients or patients with severe comorbid conditions using tamoxifen as the primary therapy

Doxorubicin-induced congestive heart failure in elderly patients with metastatic breast cancer, with long-term follow-up : the M.D. Anderson experience

Herceptin Plus Chemotherapy Combination in Preoperative Regimen May Offer Clinical Benefit in Early Stage Breast Cancer

Suchergebnisse filtern